JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 30, 2007; DOI: 10.1124/jpet.107.132407


0022-3565/08/3243-1037-1044$20.00
JPET 324:1037-1044, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.132407v1
324/3/1037    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Humar, M.
Right arrow Articles by Pannen, B. H.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Humar, M.
Right arrow Articles by Pannen, B. H.J.

INFLAMMATION, IMMUNOPHARMACOLOGY, AND ASTHMA

Thionamides Inhibit the Transcription Factor Nuclear Factor-{kappa}B by Suppression of Rac1 and Inhibitor of {kappa}B Kinase {alpha}

Matjaz Humar, Hannah Dohrmann, Philipp Stein, Nikolaos Andriopoulos, Ulrich Goebel, Martin Roesslein, Rene Schmidt, Christian I. Schwer, Torsten Loop, Klaus K. Geiger, Heike L. Pahl, and Benedikt H.J. Pannen

Center for Clinical Research, Department of Anesthesiology, University Hospital Freiburg, Freiburg, Germany (M.H., H.D., P.S., U.G., M.R., R.S., C.I.S., T.L., K.K.G., H.L.P.); Department of Medicine IV and Kidney Research Center Cologne, University of Cologne, Cologne, Germany (N.A.); and Department of Anesthesiology, University Hospital Duesseldorf, Duesseldorf, Germany (B.H.J.P.)

Thionamides, inhibitors of the thyroid peroxidase-mediated iodination, are clinically used in the treatment of hyperthyroidism. However, the use of antithyroid drugs is associated with immunomodulatory effects, and recent studies with thionamide-related heterocyclic thioderivates demonstrated direct anti-inflammatory and immunosuppressive properties. Using primary human T-lymphocytes, we show that the heterocyclic thionamides carbimazole and propylthiouracil inhibit synthesis of the proinflammatory cytokines tumor necrosis factor (TNF){alpha} and interferon (IFN){gamma}. In addition, DNA binding of nuclear factor (NF)-{kappa}B, a proinflammatory transcription factor that regulates both TNF{alpha} and IFN{gamma} synthesis, and NF-{kappa}B-dependent reporter gene expression were reduced. Abrogation of NF-{kappa}B activity was accompanied by reduced phosphorylation and proteolytic degradation of inhibitor of {kappa}B (I{kappa}B){alpha}, the inhibitory subunit of the NF-{kappa}B complex. Carbimazole inhibited NF-{kappa}B via the small GTPase Rac-1, whereas propylthiouracil inhibited the phosphorylation of I{kappa}B{alpha} by its kinase inhibitor of {kappa}B kinase {alpha}. Methimazole had no effect on NF-{kappa}B induction, demonstrating that drug potency correlated with the chemical reactivity of the thionamide-associated sulfur group. Taken together, our data demonstrate that thioureylenes with a common, heterocyclic structure inhibit inflammation and immune function via the NF-{kappa}B pathway. Our results may explain the observed remission of proinflammatory diseases upon antithyroid therapy in hyperthyroid patients. The use of related thioureylenes may provide a new therapeutic basis for the development and application of anti-inflammatory compounds.


Received October 1, 2007; accepted November 29, 2007.

Address correspondence to: Dr. Matjaz Humar, Center for Clinical Research, Breisacher Strasse 66, D-79106 Freiburg, Germany. E-mail: humar{at}ana1.ukl.uni-freiburg.de




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Humar, C. Graetz, M. Roesslein, U. Goebel, K. K. Geiger, B. Heimrich, and B. H. J. Pannen
Heterocyclic Thioureylenes Protect from Calcium-Dependent Neuronal Cell Death
Mol. Pharmacol., March 1, 2009; 75(3): 667 - 676.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.